Researchers from Rice University and Baylor College of Medicine have developed a new treatment that eliminates advanced-stage ...

The Phase I trial conducted concurrently in China and the United States, was designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary anti-tumor activity ...

At present, education is not considered a high-risk industry for malignant mesothelioma. Off Education employees do not fit the typical patient profile of mesothelioma and asbestos exposure. Despite ...

You can see details of the main clinical trial on the UCL website. HIT-Meso aims to find out how well a new therapy, called Proton Beam Therapy, can be used to treat pleural mesothelioma patients.